Prof. Utpal Tatu

Utpal Tatu obtained his PhD from Indian Institute of Science, Bangalore, India and did post-doctoral research at Yale University, New Haven, Connecticut, USA. His research focuses on Global health with a particular focus on neglected disease causing organisms with an emphasis on developing better methods of diagnosis and treatment for human and animal infections. His research work is covered in the editorials of scientific magazines such as Science and Nature Medicine. He is one of the early proponents of One health approach globally and was invited to give a TED talk on One Health in 2013. Prof Tatu is on the advisory board One Health Institute, University of Zurich in Switzerland.

Accolades:
Prof. Tatu has headed several multi-institutional projects with bilateral collaborations with international research laboratories and industries in UK, Switzerland, Denmark, Brazil, France and USA. He is a recipient of national and international awards such as Ranbaxy Research Award, Birla Science Prize and serves on the editorial board of 1). Molecular Cellular Proteomics affiliated with ASBMB, 2). Parasitology journal published by Cambridge Press and 3). New Microbe New Infection journal published by Springer. He also serves on the board of Biotech industries in India and abroad. Prof. Tatu is an elected fellow of the Indian Academy of Sciences and Ex President of the Proteomic Society of India. He is also an invited member of the research advisory board of Malaria Elimination Research Alliance, ICMR.

A Successful Entrepreneur:
Prof Tatu has founded an entrepreneurial initiative out of Indian Institute of Science called Equine Biotech Pvt Ltd that focuses on human, animal and environment interactions in the spread of infections and antimicrobial resistance through One Health approach. Equine Biotech creates diagnostic products and provides service to animal health industry, including dairy, horse racing, companion animals and avian. During the pandemic, Equine Biotech was one of the first from academia to develop a RTPCR kit for Covid19 that was approved by ICMR. Prof Tatu also helped GOI and the state government in managing the pandemic through his decades of experience in fighting infectious diseases.

Industry Partnerships:
Prof. Tatu’s research extensively utilizes tools of Genomics and mass spectrometry-based Proteomics and Metabolomics. Prof Tatu is well known for his mentorship to biopharma industry. He has served as a member of the United States Pharmacopoeia Expert panel for Biologics. As a part of USP panel he has conducted series of workshops on mass spectrometry-based characterization of biotherapeutics for biosimilar industry in India. Prof Tatu is an entrepreneur and advises Government of Karnataka on investments in Biotech based startups and serves on the advisory board of national and international biotech companies.